Auxilium Pharmaceuticals, Inc. (AUXL) announced that the U.S. Food and Drug Administration's Arthritis Advisory Committee will review XIAFLEX during an advisory committee hearing, tentatively scheduled to take place on September 16, 2009. The Arthritis Advisory Committee is an official advisory committee of the FDA'sDivision of Anesthesia, Analgesia and Rheumatology Products.
XIAFLEX is a novel, first-in-class, orphan-designated, biologic for the treatment of Dupuytren's contracture.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.